Cargando…
Overcoming COVID-19 in West African countries: is herd immunity an option?
The coronavirus infection (COVID-19) to date has no vaccine or effective treatment. Herd immunity offers indirect protection to susceptible members of the population. If the acquired immunity of a community rises above 67%, then a gradual decline in the number of incident cases is recorded. How many...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687463/ https://www.ncbi.nlm.nih.gov/pubmed/33282058 http://dx.doi.org/10.11604/pamj.supp.2020.35.2.24217 |
_version_ | 1783613524556120064 |
---|---|
author | Ilesanmi, Olayinka Stephen Akande, Abayomi Afolabi, Aanuoluwapo Adeyimika |
author_facet | Ilesanmi, Olayinka Stephen Akande, Abayomi Afolabi, Aanuoluwapo Adeyimika |
author_sort | Ilesanmi, Olayinka Stephen |
collection | PubMed |
description | The coronavirus infection (COVID-19) to date has no vaccine or effective treatment. Herd immunity offers indirect protection to susceptible members of the population. If the acquired immunity of a community rises above 67%, then a gradual decline in the number of incident cases is recorded. How many deaths would have occurred in the West African countries by the time at least 67% of our people are infected with the present case fatality rate (CFR)? The objective of this study was to develop a forecast of the number of COVID-19 deaths that would be recorded to attain herd immunity for each country in West-Africa. We predicted the numbers of deaths using publicly available demographic and COVID-19 data. To attain herd immunity in West Africa 5.2 million COVID-19 deaths would have occurred assuming the CFR is maintained at the current rates in the region. Attention should be focused on strategies that would limit the spread of infection and protect the most vulnerable population groups while the race to develop an effective vaccine should be hastened. |
format | Online Article Text |
id | pubmed-7687463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-76874632020-12-03 Overcoming COVID-19 in West African countries: is herd immunity an option? Ilesanmi, Olayinka Stephen Akande, Abayomi Afolabi, Aanuoluwapo Adeyimika Pan Afr Med J Perspectives The coronavirus infection (COVID-19) to date has no vaccine or effective treatment. Herd immunity offers indirect protection to susceptible members of the population. If the acquired immunity of a community rises above 67%, then a gradual decline in the number of incident cases is recorded. How many deaths would have occurred in the West African countries by the time at least 67% of our people are infected with the present case fatality rate (CFR)? The objective of this study was to develop a forecast of the number of COVID-19 deaths that would be recorded to attain herd immunity for each country in West-Africa. We predicted the numbers of deaths using publicly available demographic and COVID-19 data. To attain herd immunity in West Africa 5.2 million COVID-19 deaths would have occurred assuming the CFR is maintained at the current rates in the region. Attention should be focused on strategies that would limit the spread of infection and protect the most vulnerable population groups while the race to develop an effective vaccine should be hastened. The African Field Epidemiology Network 2020-07-06 /pmc/articles/PMC7687463/ /pubmed/33282058 http://dx.doi.org/10.11604/pamj.supp.2020.35.2.24217 Text en ©Olayinka Stephen Ilesanmi et al. https://creativecommons.org/licenses/by/4.0 Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Perspectives Ilesanmi, Olayinka Stephen Akande, Abayomi Afolabi, Aanuoluwapo Adeyimika Overcoming COVID-19 in West African countries: is herd immunity an option? |
title | Overcoming COVID-19 in West African countries: is herd immunity an option? |
title_full | Overcoming COVID-19 in West African countries: is herd immunity an option? |
title_fullStr | Overcoming COVID-19 in West African countries: is herd immunity an option? |
title_full_unstemmed | Overcoming COVID-19 in West African countries: is herd immunity an option? |
title_short | Overcoming COVID-19 in West African countries: is herd immunity an option? |
title_sort | overcoming covid-19 in west african countries: is herd immunity an option? |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687463/ https://www.ncbi.nlm.nih.gov/pubmed/33282058 http://dx.doi.org/10.11604/pamj.supp.2020.35.2.24217 |
work_keys_str_mv | AT ilesanmiolayinkastephen overcomingcovid19inwestafricancountriesisherdimmunityanoption AT akandeabayomi overcomingcovid19inwestafricancountriesisherdimmunityanoption AT afolabiaanuoluwapoadeyimika overcomingcovid19inwestafricancountriesisherdimmunityanoption |